Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 3/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.50 |
| ▸ | HPGD | P15428 | 2/20 | 0.50 |
| ▸ | THRB | P10828 | 2/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.50 |
| ▸ | APEX1 | P27695 | 1/20 | 0.50 |
| ▸ | BLM | P54132 | 1/20 | 0.50 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.50 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.50 |
| ▸ | ATM | Q13315 | 1/20 | 0.50 |
| ▸ | TBXAS1 | P24557 | 2/20 | 0.49 |
| ▸ | GSK3B | P49841 | 2/20 | 0.49 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.48 |
| ▸ | F3 | P13726 | 1/20 | 0.47 |
| ▸ | NPC1 | O15118 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6659979 | 1.00 | MAPT (0.50) | MAPTALDH1A1KDM4EHPGDTHRB | |
| SCHEMBL8419202 | 1.00 | MAPT (0.50) | MAPTALDH1A1KDM4EHPGDTHRB | |
| Butyric Acid SCHEMBL7821663 | 0.91 | RAB9A (0.50) | MAPTALDH1A1KDM4EHPGDTHRB | |
| Butyric Acid SCHEMBL7821661 | 0.91 | RAB9A (0.50) | MAPTALDH1A1KDM4EHPGDTHRB | |
| SCHEMBL11652530 | 0.87 | S100B (0.57) | MAPTALDH1A1KDM4ETHRBCYP1A2 | |
| SCHEMBL5173409 | 0.87 | TBXAS1 (0.58) | ALDH1A1KDM4EHPGDCYP3A4TBXAS1 | |
| SCHEMBL489474 | 0.87 | ALOX5 (0.48) | MAPTALDH1A1KDM4EHPGDTHRB | |
| SCHEMBL11765552 | 0.86 | ALDH1A1 (0.49) | MAPTALDH1A1KDM4EHPGDTHRB | |
| SCHEMBL30752453 | 0.86 | ALDH1A1 (0.49) | MAPTALDH1A1KDM4EHPGDTHRB | |
| SCHEMBL11765557 | 0.86 | ALDH1A1 (0.49) | MAPTALDH1A1KDM4EHPGDTHRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 60 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4687823-A1 | COMPOSITION USEFUL FOR SLOWING DOWN DEGRADATION CAUSED BY LIGHT, HEAT AND/OR THE OXIDATION OF AN ACTIVE COMPOUND | Sensient Cosmetic Technologies (FR) | 2026-02-11 | — | — | EP | claimed |
| WO-2024208941-A1 | COMPOSITION USEFUL FOR SLOWING DOWN DEGRADATION CAUSED BY LIGHT, HEAT AND/OR THE OXIDATION OF AN ACTIVE COMPOUND | SENSIENT COSMETIC TECHNOLOGIES (FR) | 2024-10-10 | — | — | WO | claimed |
| CN-117143811-A | Human umbilical cord mesenchymal stem cell culture medium and preparation method thereof | 贵州中观生物技术有限公司 | 2023-12-01 | — | — | CN | claimed |
| EP-2662068-B1 | OIL-IN-WATER EMULSION COMPOSITION | KAO CORP (JP) | 2017-07-05 | — | — | EP | claimed |
| EP-0812309-B1 | PROCESS FOR PREPARATION OF CINNAMATE SUNSCREEN AGENTS | ISP VAN DYK INC (US) | 2000-04-26 | — | — | EP | claimed |
| US-5989529-A | Substantive topical composition | SCHERING-PLOUGH HEALTHCARE PRODUCTS, INC. (US) | 1999-11-23 | — | — | US | claimed |
| EP-4687823-A1 | COMPOSITION USEFUL FOR SLOWING DOWN DEGRADATION CAUSED BY LIGHT, HEAT AND/OR THE OXIDATION OF AN ACTIVE COMPOUND | Sensient Cosmetic Technologies (FR) | 2026-02-11 | — | — | EP | disclosed |
| WO-2025136963-A1 | CATIONIC MICRO-VESICLES AND FUNCTIONALIZED EXOSOME-LIKE VECTORS FOR THE DELIVERY OF FUNCTIONAL AGENT TO THE SKIN | COTY INC. (US) | 2025-06-26 | — | — | WO | disclosed |
| CN-119980263-A | Sun-screening agent, sun-screening composition and preparation method of sun-screening agent | 牛吉娜 | 2025-05-13 | — | — | CN | disclosed |
| EP-4514478-A1 | SOLID COSMETIC SUNSCREEN COMPOSITION COMPRISING AT LEAST ONE CAVITY | Capsum (FR) | 2025-03-05 | — | — | EP | disclosed |
| WO-2024208941-A1 | COMPOSITION USEFUL FOR SLOWING DOWN DEGRADATION CAUSED BY LIGHT, HEAT AND/OR THE OXIDATION OF AN ACTIVE COMPOUND | SENSIENT COSMETIC TECHNOLOGIES (FR) | 2024-10-10 | — | — | WO | disclosed |
| CN-117143811-A | Human umbilical cord mesenchymal stem cell culture medium and preparation method thereof | 贵州中观生物技术有限公司 | 2023-12-01 | — | — | CN | disclosed |
| WO-2023209011-A1 | SOLID COSMETIC SUNSCREEN COMPOSITION COMPRISING AT LEAST ONE CAVITY | CAPSUM (FR) | 2023-11-02 | — | — | WO | disclosed |
| EP-1576061-A2 | TITANIUM DIOXIDE COATED WITH SILICON DIOXIDE | Degussa AG (DE) | 2005-09-21 | — | — | EP | disclosed |
| US-20040254241-A1 | Enzyme inhibitor; cognition activators | KYOWA HAKKO KOGYO CO., LTD. (JP) | 2004-12-16 | — | — | US | disclosed |
| CN-1542109-A | Method for extracting sun choke essential oil and sun choke brain by enzymolysis-vapor distillation process | 广州大学 | 2004-11-03 | — | — | CN | disclosed |
| WO-2004056927-A2 | TITANIUM DIOXIDE COATED WITH SILICON DIOXIDE | DEGUSSA AG (DE) | 2004-07-08 | — | — | WO | disclosed |
| EP-1431280-A1 | ARYL SULFAMATE DERIVATIVES | Kyowa Hakko Kogyo Co., Ltd (JP) | 2004-06-23 | — | — | EP | disclosed |
| EP-0944613-A1 | NOVEL BENZOPYRAN DERIVATIVES | C & C Research Laboratories (KR) | 1999-09-29 | — | — | EP | disclosed |
| WO-1998025916-A1 | NOVEL BENZOPYRAN DERIVATIVES | C & C RESEARCH LABORATORIES (KR) | 1998-06-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040254241-A1 | Enzyme inhibitor; cognition activators | SULT1A1, STS, CYP26A1 | MAPT 3105/4885ALDH1A1 1187/4885KDM4E 3017/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.